Mortality rate is associated with aripiprazole once-monthly and oral asenapine administration

Asian J Psychiatr. 2019 Jan:39:22. doi: 10.1016/j.ajp.2018.11.010. Epub 2018 Nov 15.

Authors

Hidenobu Suzuki¹, Hiroyuki Hibino², Yuichi Inoue³, Atsuhiko Takaya²

Affiliations

¹ Department of Psychiatry, Suzuki Clinic, Tokyo 168-0065, Japan. Electronic address: suzuhiromarket@yahoo.co.jp.
² Department of Psychiatry, Fukui Kinen Hospital, Kanagawa 238-0115, Japan.
³ Department of Psychiatry, Shakomae Kokorono Clinic, Tokyo 116-0011, Japan.

PMID: 30472350
DOI: 10.1016/j.ajp.2018.11.010

No abstract available

Publication types

Letter

MeSH terms

Administration, Oral
Adult
Antipsychotic Agents / administration & dosage
Antipsychotic Agents / adverse effects*
Aripiprazole / administration & dosage
Aripiprazole / adverse effects*
Delayed-Action Preparations
Dibenzocycloheptenes
Female
Heterocyclic Compounds, 4 or More Rings / administration & dosage
Heterocyclic Compounds, 4 or More Rings / adverse effects*
Humans
Japan
Male
Middle Aged
Retrospective Studies
Schizophrenia / drug therapy*
Schizophrenia / mortality*
Suicide / statistics & numerical data*

Substances

Antipsychotic Agents
Delayed-Action Preparations
Dibenzocycloheptenes
Heterocyclic Compounds, 4 or More Rings
Aripiprazole
asenapine